Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07660406

Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT

Conditions: Keloid

Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: No
Phase: PHASE1, PHASE2
Enrollment: 30
Sponsor: Peking Union Medical College Hospital

Location: Peking Union Medical College Hospital Beijing

Summary

Keloids are often described as benign dermal fibroproliferative lesions characterized by increased growth beyond the boundaries of the original wound margin.Fibroblasts are considered to be the key cellular mediators of fibrogenesis in keloid scars. Thus this prospective study is going to investigate whether 68Ga-RGD PET/CT may provide evidence for diagnosis and evaluate the effectiveness of treatment.

Eligibility Criteria

Inclusion Criteria: \- Patients with a clinical diagnosis of keloids Able to obtain informed consent Exclusion Criteria: \- Pregnant women, children, patients with allergies to contrast media Patients with claustrophobia

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07660406). StuddyBuddy aggregates publicly available trial information.